Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update shows safety, tolerability, and pharmacokinetics of repeat doses of GSK1014802. The study has completed in participants with bipol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Bipolar Disorder

Drugs mentioned

• GSK1014802

Snippet

Sponsor: Biogen | Conditions: Bipolar Depression, Bipolar Disorder | Phase 1 | Status: COMPLETED